Cambrex Corporation

Cambrex Corporation

[[File:

Cambrex Corporation Logo

|200px|alt=]]

Type	Public
Key people	Thomas Loewald (CEO)
Industry	Pharmaceutical
Products	Active Pharmaceutical Ingredients (APIs), Drug Products
Revenue	$532 million (2019)
Employees	2,000+

Cambrex Corporation is a leading global contract development and manufacturing organization (CDMO) that specializes in the development, manufacturing, and supply of active pharmaceutical ingredients (APIs) and drug products. Founded in 1981, Cambrex has established itself as a key player in the pharmaceutical industry, providing services to a wide range of pharmaceutical and biotechnology companies.

History

Cambrex was founded in 1981 and has grown through a series of strategic acquisitions and expansions. The company initially focused on specialty chemicals but gradually shifted its focus towards the pharmaceutical industry. Over the years, Cambrex has expanded its capabilities and geographic presence, establishing facilities in North America and Europe.

Operations

Cambrex operates several state-of-the-art facilities across the United States and Europe. These facilities are equipped to handle a wide range of chemical and biological processes, enabling Cambrex to offer comprehensive services from early-stage development to commercial manufacturing.

Cambrex Manufacturing Facility

Services

Cambrex provides a variety of services, including:

• Custom development and manufacturing of APIs
• Drug product formulation and manufacturing
• Analytical and stability testing
• Regulatory support and quality assurance

The company is known for its expertise in complex chemistry and its ability to handle highly potent compounds.

Research and Development

Cambrex invests significantly in research and development to stay at the forefront of pharmaceutical manufacturing technology. The company collaborates with clients to develop innovative solutions that meet the evolving needs of the pharmaceutical industry.

Corporate Social Responsibility

Cambrex is committed to sustainable practices and corporate social responsibility. The company focuses on reducing its environmental impact, ensuring the safety and well-being of its employees, and supporting the communities in which it operates.

See also

• Pharmaceutical industry
• Active pharmaceutical ingredient
• Contract manufacturing organization
• Drug development

References

• Cambrex Corporation official website
• Industry reports and publications